Impurity reference standards
Pantoprazole impurities & reference standards
Characterised Pantoprazole impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
46reference materials
2isotope-labelled
COAHPLC · NMR · MS on request
Parent API: Pantoprazole Sodium
138786-67-1 · C16H15F2N3NaO4S
![1-(5-(Difluoromethoxy)-1H-benzo[d]imidazol-2-yl)-3-methoxy-4-oxo-1,4-dihydropyridine-2-carboxylic Acid chemical structure](/media/structures/QDKLFWXHNUPUHR-UHFFFAOYSA-N.svg)
1-(5-(Difluoromethoxy)-1H-benzo[d]imidazol-2-yl)-3-methoxy-4-oxo-1,4-dihydropyridine-2-carboxylic Acid
- CAS
- 2512209-15-1
- Formula
- C15H11F2N3O5
- MW
- 351.26 g/mol
VQ-041319
2-Chloromethyl-3,4-dimethoxypyridine Hydrochloride
- CAS
- 72830-09-2
- Formula
- C8H11Cl2NO2
- MW
- 224.08 g/mol
In stock
4-Chloro-2-(chloromethyl)-3-methoxypyridine Hydrochloride
- CAS
- 503058-51-3
- Formula
- C7H8Cl3NO
- MW
- 228.5 g/mol
VQ-033047
4-Chloro-3-methoxy-2-methyl-pyridine hydrochloride
- CAS
- 1951439-74-9
- Formula
- C7H9Cl2NO
- MW
- 194.06 g/mol
VQ-041324
![5-(Difluoromethoxy)-1,3-dihydro-2H-benzo[d]imidazol-2-one chemical structure](/media/structures/WGSZJVSNGVDBHX-UHFFFAOYSA-N.svg)
5-(Difluoromethoxy)-1,3-dihydro-2H-benzo[d]imidazol-2-one
- CAS
- 1806469-15-7
- Formula
- C8H6F2N2O2
- MW
- 200.14 g/mol
VQ-033048
![5-Methoxy-1-methyl-1,3-dihydro-2H-benzo[d]imidazole-2-thione chemical structure](/media/structures/ZDXVDGBQLMIQFX-UHFFFAOYSA-N.svg)
5-Methoxy-1-methyl-1,3-dihydro-2H-benzo[d]imidazole-2-thione
- CAS
- 58764-00-4
- Formula
- C9H10N2OS
- MW
- 194.26 g/mol
VQ-041323
FAQs — Pantoprazole impurities
Which Pantoprazole impurities do you supply?
We list 46 Pantoprazole-related reference materials, including process impurities, degradation products, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Pantoprazole impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Pantoprazole impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Pantoprazole impurity standards
We reply within one business day with price, pack options, lead time and documentation.